Boston Scientific Discontinues Acurate TAVR Program After Clinical Trial Failure
Boston Scientific announced the global discontinuation of its Acurate aortic valve replacement systems after the devices failed to meet non-inferiority criteria in clinical trials.
Elixir Medical's DynamX Bioadaptor Shows Sustained Clinical Benefits Over Drug-Eluting Stents at Three Years
Elixir Medical's DynamX coronary bioadaptor demonstrated significantly lower target lesion failure rates compared to drug-eluting stents at three years (2.7% vs 7.2%, p=0.030).
Basil Systems Secures $11.5M to Revolutionize Life Sciences Decision-Making with AI
Basil Systems has raised $11.5 million in funding led by Golden Ventures, with participation from Hearst Ventures and Argosy Capital, to expand its AI-powered product lifecycle intelligence platform.
Medtronic Plans to Separate Diabetes Business into Standalone Company
Medtronic has announced plans to separate its Diabetes business into an independent, publicly traded company within the next 18 months, enabling both entities to focus on their core strengths and growth opportunities.
Brain Navi Partners with First Securities for IPO, Aims to Accelerate Global MedTech Expansion
Brain Navi, a neurosurgical robotics company, has initiated IPO counseling with First Securities Inc., marking a significant step toward entering the capital market.
Medtronic's Affera™ PFA Technologies Show Promising Results for Atrial Fibrillation Treatment
One-year clinical trial data for Medtronic's investigational Sphere-360™ single-shot PFA catheter demonstrated 88% freedom from arrhythmia recurrence in paroxysmal atrial fibrillation patients, with no reported safety events in the optimized waveform subgroup.
Medtronic's Hugo Robotic Surgery System Meets Primary Endpoints in Landmark Urologic Trial
Medtronic's Expand URO clinical trial, the largest multi-center prospective IDE study for robotic-assisted urologic surgery in the U.S., successfully met both primary safety and effectiveness endpoints with 137 patients.
FDA Approves Medtronic's OmniaSecure: World's Smallest Defibrillation Lead for Cardiac Patients
Medtronic has received FDA approval for OmniaSecure, the world's smallest defibrillation lead at 1.6mm diameter, designed for placement in the right ventricle to treat life-threatening cardiac arrhythmias.
Smart Drug Delivery Systems Market Poised for 17% Growth as Chronic Disease Management Evolves
The global smart drug delivery systems market reached $12 billion in 2024 and is projected to grow at a CAGR of 17% through 2034, driven by rising chronic disease prevalence and technological advancements.
Medtronic Submits Interoperable Insulin Pump to FDA, Advancing Abbott Partnership
Medtronic has submitted 510(k) applications to the FDA for its MiniMed 780G pump as an alternate controller enabled device and its SmartGuard algorithm as an interoperable automated glycemic controller.